通过HDAC3和YY1辅因子对RASAL1的表观遗传抑制促进纤维细胞-肌纤维细胞过渡和纤维化
Fang Chen1,2, Lijun Zhang3, Weiying Liu4
1Yancheng Key Laboratory of Molecular Epigenetics, Yancheng Medical Research Center of Nanjing University Medical School, The First People's Hospital of Yancheng, Yancheng 224006, China.
Research (Washington, D.C.)
|February 2, 2026
概括
基因组脱乙酶3 (HDAC3) 在表观遗传上抑制RASAL1,导致纤维化. 抑制HDAC3保留RASAL1,减少纤维细胞-肌纤维细胞过渡 (FMT),并缓解纤维化,提供治疗潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 纤维细胞-肌纤维细胞过渡 (FMT) 和纤维化是慢性病 (CKD) 的关键因素.
- 抗纤维细胞调节剂RASAL1的表观遗传抑制驱动了这一过程.
- 在纤维化中RASAL1抑制的精确机制尚未完全理解.
研究的目的:
- 在纤维化中确定RASAL1的表观遗传调节者.
- 为了研究基因组脱乙酶3 (HDAC3) 在纤维细胞-肌纤维细胞过渡 (FMT) 中的作用.
- 探索针对纤维化HDAC3-YY1-RASAL1轴的治疗策略.
主要方法:
- 使用纤维化的小鼠模型 (单边尿路阻塞,阿里斯托洛希克酸I).
- 生成纤维细胞特异性Hdac3的淘汰赛小鼠.
- 使用RGFP966.6进行HDAC3的药理抑制.
- 研究了HDAC3,YY1和RASAL1在培养纤维细胞和体内的相互作用.
主要成果:
- 增加HDAC3表达,与纤维脏中RASAL1抑制相关.
- Hdac3 淘汰赛保留了RASAL1,减弱了FMT,并减少了纤维化.
- 通过RGFP966抑制HDAC3,恢复RASAL1,抑制FMT,并缓解纤维化.
- 证实了HDAC3-YY1-RASAL1轴对FMT和纤维生成至关重要.
结论:
- 在纤维化中,HDAC3是RASAL1的关键表观遗传抑制剂.
- 针对HDAC3-YY1-RASAL1轴为CKD提供了一个潜在的治疗策略.
- 调节HDAC3和YY1可能为纤维化疾病提供更广泛的治疗益处.
相关概念视频
Cofactors and Coenzymes
87.5K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
87.5K
Cofactors and Coenzymes
12.8K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
12.8K
Epigenetic Regulation
33.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
Epigenetic Regulation
3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.9K
Cooperative Allosteric Transitions
8.7K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.7K
Phase Transitions
23.2K
Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
23.2K


